Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Benazepril | hsa00190 | Oxidative phosphorylation | 2.29E-02 | 2 | Q16718, O14521 | NDUFA5, SDHD | More | | Benazepril | hsa00240 | Pyrimidine metabolism | 4.29E-02 | 2 | P21589, P04183 | NT5E, TK1 | More | | Benazepril | hsa00310 | Lysine degradation | 2.86E-02 | 2 | Q96KQ7, Q02809 | EHMT2, PLOD1 | More | | Benazepril | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Benazepril | hsa00513 | Various types of N-glycan biosynthesis | 4.96E-02 | 1 | Q9NR34 | MAN1C1 | More | | Benazepril | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Benazepril | hsa00564 | Glycerophospholipid metabolism | 4.29E-02 | 2 | Q6P1A2, P23743 | MBOAT5, DGKA | More | | Benazepril | hsa00670 | One carbon pool by folate | 1.32E-02 | 1 | P00374 | DHFR | More | | Benazepril | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Benazepril | hsa00785 | Lipoic acid metabolism | 4.57E-02 | 1 | Q9Y234 | LIPT1 | More | | Benazepril | hsa00790 | Folate biosynthesis | 1.32E-02 | 1 | P00374 | DHFR | More | | Benazepril | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Benazepril | hsa01523 | Antifolate resistance | 1.98E-02 | 1 | P00374 | DHFR | More | | Benazepril | hsa01524 | Platinum drug resistance | 4.57E-02 | 1 | P20585 | MSH3 | More | | Benazepril | hsa02010 | ABC transporters | 2.29E-02 | 2 | P45844, P08183 | ABCG1, ABCB1 | More | | Benazepril | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Benazepril | hsa03040 | Spliceosome | 4.16E-06 | 15 | Q14562, O43143, O60508, P08579, P26368, P52298, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, SNRPB2, U2AF2, NCBP2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Benazepril | hsa03060 | Protein export | 1.90E-02 | 2 | Q15070, O76094 | OXA1L, SRP72 | More | | Benazepril | hsa03430 | Mismatch repair | 3.93E-02 | 1 | P20585 | MSH3 | More | | Benazepril | hsa04014 | Ras signaling pathway | 2.36E-02 | 8 | P42338, P20827, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Benazepril | hsa04015 | Rap1 signaling pathway | 1.98E-04 | 12 | P20827, P49767, Q96FS4, P11215, P25116, Q8TEU7, Q13009, Q7LDG7, P42338, P08514, P17252, P19174 | EFNA1, VEGFC, SIPA1, ITGAM, F2R, RAPGEF6, TIAM1, RASGRP2, PIK3CB, ITGA2B, PRKCA, PLCG1 | More | | Benazepril | hsa04022 | cGMP-PKG signaling pathway | 1.05E-02 | 3 | P24844, Q8WYR1, Q15746 | MYL9, PIK3R5, MYLK | More | | Benazepril | hsa04024 | cAMP signaling pathway | 1.40E-02 | 3 | P48058, P25116, P24844 | GRIA4, F2R, MYL9 | More | | Benazepril | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.39E-03 | 9 | P32248, P09341, P19875, P25024, P02775, P25025, P47992, Q9UBD3, P14784 | CCR7, CXCL1, CXCL2, CXCR1, PPBP, CXCR2, XCL1, XCL2, IL2RB | More | | Benazepril | hsa04062 | Chemokine signaling pathway | 5.65E-04 | 14 | P25024, P25025, P09341, P19875, P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | CXCR1, CXCR2, CXCL1, CXCL2, FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Benazepril | hsa04064 | NF-kappa B signaling pathway | 2.15E-02 | 7 | P14778, P19174, Q04759, P06239, P09341, P19875, Q06643 | IL1R1, PLCG1, PRKCQ, LCK, CXCL1, CXCL2, LTB | More | | Benazepril | hsa04070 | Phosphatidylinositol signaling system | 3.47E-02 | 4 | P0DP23, Q14643, P23743, P17252 | CALM1, ITPR1, DGKA, PRKCA | More | | Benazepril | hsa04071 | Sphingolipid signaling pathway | 4.49E-02 | 4 | P17252, P21453, Q9BX95, P10415 | PRKCA, S1PR1, SGPP1, BCL2 | More | | Benazepril | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Benazepril | hsa04080 | Neuroactive ligand-receptor interaction | 2.50E-03 | 7 | P48058, Q15722, P21453, O00398, P25116, P21462, Q16581 | GRIA4, LTB4R, S1PR1, P2RY10, F2R, FPR1, C3AR1 | More | | Benazepril | hsa04114 | Oocyte meiosis | 3.27E-02 | 3 | Q9UJX4, P30260, Q16539 | ANAPC5, CDC27, MAPK14 | More | | Benazepril | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Benazepril | hsa04145 | Phagosome | 8.42E-03 | 6 | Q15080, P14598, Q13509, P68371, Q13488, O60603 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, TLR2 | More | | Benazepril | hsa04151 | PI3K-Akt signaling pathway | 3.70E-02 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | | Benazepril | hsa04210 | Apoptosis | 7.52E-04 | 8 | P04637, Q13489, O76075, P24522, P43234, Q14643, P42575, P63261 | TP53, BIRC3, DFFB, GADD45A, CTSO, ITPR1, CASP2, ACTG1 | More | | Benazepril | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Benazepril | hsa04217 | Necroptosis | 2.64E-03 | 10 | P01375, P01568, P48023, Q13489, Q13546, Q14765, Q6FI13, Q99878, P10415, O43633 | TNF, IFNA21, FASLG, BIRC3, RIPK1, STAT4, H2AC18; H2AC19, H2AC14, BCL2, CHMP2A | More | | Benazepril | hsa04270 | Vascular smooth muscle contraction | 4.65E-02 | 2 | Q15746, P24844 | MYLK, MYL9 | More | | Benazepril | hsa04350 | TGF-beta signaling pathway | 4.88E-02 | 1 | P37173 | TGFBR2 | More | | Benazepril | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Benazepril | hsa04371 | Apelin signaling pathway | 1.00E-02 | 7 | P63218, P50151, Q8WYR1, Q14814, Q14344, Q13485, P84022 | GNG5, GNG10, PIK3R5, MEF2D, GNA13, SMAD4, SMAD3 | More | | Benazepril | hsa04510 | Focal adhesion | 3.36E-02 | 3 | P08514, Q15746, P24844 | ITGA2B, MYLK, MYL9 | More | | Benazepril | hsa04512 | ECM-receptor interaction | 2.44E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Benazepril | hsa04514 | Cell adhesion molecules | 4.65E-02 | 2 | P16109, O00501 | SELP, CLDN5 | More | | Benazepril | hsa04530 | Tight junction | 7.42E-04 | 4 | Q8TEU7, O00501, Q14247, P24844 | RAPGEF6, CLDN5, CTTN, MYL9 | More | | Benazepril | hsa04540 | Gap junction | 1.29E-02 | 4 | P17252, Q13509, P68371, Q14643 | PRKCA, TUBB3, TUBB2C, ITPR1 | More | | Benazepril | hsa04610 | Complement and coagulation cascades | 9.44E-04 | 4 | P25116, P00734, P0C0L4, P10909 | F2R, F2, C4A, CLU | More | | Benazepril | hsa04611 | Platelet activation | 1.19E-06 | 7 | Q14643, P25116, P08514, Q15746, Q8WYR1, P63261, P07359 | ITPR1, F2R, ITGA2B, MYLK, PIK3R5, ACTG1, GP1BA | More | | Benazepril | hsa04613 | Neutrophil extracellular trap formation | 4.72E-03 | 12 | P17252, O60603, P08246, P04908, Q6FI13, Q93077, P68431, P14598, Q15080, P21462, O43315, Q16539 | PRKCA, TLR2, ELA2, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, FPR1, AQP9, MAPK14 | More | | Benazepril | hsa04614 | Renin-angiotensin system | 1.52E-02 | 1 | P50052 | AGTR2 | More | | Benazepril | hsa04623 | Cytosolic DNA-sensing pathway | 2.86E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Benazepril | hsa04640 | Hematopoietic cell lineage | 1.37E-02 | 7 | P14778, P27930, P11215, P25063, P07766, P01732, P09564 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD7 | More | | Benazepril | hsa04650 | Natural killer cell mediated cytotoxicity | 2.83E-04 | 10 | P19174, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, P26717, P26715 | PLCG1, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, KLRC2, KLRC1 | More | | Benazepril | hsa04658 | Th1 and Th2 cell differentiation | 4.19E-06 | 10 | Q04759, P07766, P20963, P09693, P19174, P06239, P23771, Q9UL17, P14784, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, LCK, GATA3, TBX21, IL2RB, RUNX3 | More | | Benazepril | hsa04659 | Th17 cell differentiation | 9.05E-05 | 11 | Q04759, P19174, P06239, P14784, P14778, Q9UL17, P84022, Q13485, P08238, P07766, P20963 | PRKCQ, PLCG1, LCK, IL2RB, IL1R1, TBX21, SMAD3, SMAD4, HSP90AB1, CD3E, CD247 | More | | Benazepril | hsa04660 | T cell receptor signaling pathway | 1.31E-04 | 11 | Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239 | PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK | More | | Benazepril | hsa04662 | B cell receptor signaling pathway | 1.74E-02 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Benazepril | hsa04664 | Fc epsilon RI signaling pathway | 2.47E-02 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Benazepril | hsa04666 | Fc gamma R-mediated phagocytosis | 1.88E-02 | 4 | P23528, O14494, P14598, P17252 | CFL1, PLPP1, NCF1, PRKCA | More | | Benazepril | hsa04672 | Intestinal immune network for IgA production | 1.35E-02 | 2 | P29965, P13765 | CD40LG, HLA-DOB | More | | Benazepril | hsa04713 | Circadian entrainment | 2.60E-02 | 4 | P0DP23, P17252, P62873, Q14643 | CALM1, PRKCA, GNB1, ITPR1 | More | | Benazepril | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Benazepril | hsa04720 | Long-term potentiation | 5.06E-03 | 4 | P17252, Q16566, P0DP23, Q14643 | PRKCA, CAMK4, CALM1, ITPR1 | More | | Benazepril | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Benazepril | hsa04724 | Glutamatergic synapse | 2.94E-02 | 2 | P48058, Q9NSB8 | GRIA4, HOMER2 | More | | Benazepril | hsa04725 | Cholinergic synapse | 2.72E-03 | 5 | Q14643, P17252, P62873, Q16566, P10415 | ITPR1, PRKCA, GNB1, CAMK4, BCL2 | More | | Benazepril | hsa04726 | Serotonergic synapse | 4.49E-02 | 4 | Q14643, P17252, P62873, P33260 | ITPR1, PRKCA, GNB1, CYP2C18 | More | | Benazepril | hsa04744 | Phototransduction | 1.02E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Benazepril | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.24E-03 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | | Benazepril | hsa04810 | Regulation of actin cytoskeleton | 1.38E-03 | 4 | P24844, Q15746, P08514, P25116 | MYL9, MYLK, ITGA2B, F2R | More | | Benazepril | hsa04912 | GnRH signaling pathway | 3.89E-02 | 3 | P17252, Q14643, P0DP23 | PRKCA, ITPR1, CALM1 | More | | Benazepril | hsa04914 | Progesterone-mediated oocyte maturation | 1.46E-02 | 3 | Q9UJX4, P30260, Q16539 | ANAPC5, CDC27, MAPK14 | More | | Benazepril | hsa04918 | Thyroid hormone synthesis | 3.16E-02 | 2 | P17252, P27824 | PRKCA, CANX | More | | Benazepril | hsa04921 | Oxytocin signaling pathway | 6.37E-03 | 3 | Q15746, P24844, Q8WYR1 | MYLK, MYL9, PIK3R5 | More | | Benazepril | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Benazepril | hsa04925 | Aldosterone synthesis and secretion | 1.14E-03 | 5 | Q14643, P15336, P0DP23, P17252, Q16566 | ITPR1, ATF2, CALM1, PRKCA, CAMK4 | More | | Benazepril | hsa04927 | Cortisol synthesis and secretion | 3.20E-02 | 2 | Q14643, P15336 | ITPR1, ATF2 | More | | Benazepril | hsa04932 | Non-alcoholic fatty liver disease | 2.44E-03 | 5 | P01375, P49841, P48023, Q16718, O14521 | TNF, GSK3B, FASLG, NDUFA5, SDHD | More | | Benazepril | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Benazepril | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Benazepril | hsa04966 | Collecting duct acid secretion | 2.86E-02 | 2 | Q13488, Q9Y666 | TCIRG1, SLC12A7 | More | | Benazepril | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Benazepril | hsa04976 | Bile secretion | 3.32E-02 | 2 | O43315, P08183 | AQP9, ABCB1 | More | | Benazepril | hsa05020 | Prion disease | 4.60E-03 | 9 | Q16718, O14521, Q14643, Q13509, P68371, P49841, P14598, Q15080, Q16539 | NDUFA5, SDHD, ITPR1, TUBB3, TUBB2C, GSK3B, NCF1, NCF4, MAPK14 | More | | Benazepril | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.09E-03 | 12 | Q14643, Q13509, P68371, P49841, P10415, Q16718, O14521, Q13561, P17252, Q16539, Q08752, P0DP23 | ITPR1, TUBB3, TUBB2C, GSK3B, BCL2, NDUFA5, SDHD, DCTN2, PRKCA, MAPK14, PPID, CALM1 | More | | Benazepril | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Benazepril | hsa05130 | Pathogenic Escherichia coli infection | 2.51E-02 | 3 | Q14247, O00501, P25116 | CTTN, CLDN5, F2R | More | | Benazepril | hsa05132 | Salmonella infection | 1.11E-02 | 8 | Q9UJU2, Q13546, Q13489, P10415, O60603, Q13561, Q13509, P68371 | LEF1, RIPK1, BIRC3, BCL2, TLR2, DCTN2, TUBB3, TUBB2C | More | | Benazepril | hsa05133 | Pertussis | 2.02E-03 | 4 | P0DP23, P23528, P09871, P0C0L4 | CALM1, CFL1, C1S, C4A | More | | Benazepril | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Benazepril | hsa05143 | African trypanosomiasis | 3.01E-03 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Benazepril | hsa05146 | Amoebiasis | 2.21E-04 | 8 | P09341, P19875, P14778, P27930, P42338, P11215, P05089, P12814 | CXCL1, CXCL2, IL1R1, IL1R2, PIK3CB, ITGAM, ARG1, ACTN1 | More | | Benazepril | hsa05152 | Tuberculosis | 4.18E-03 | 7 | Q13488, P0DP23, P48382, O60603, P10415, P01568, Q9UDY8 | TCIRG1, CALM1, RFX5, TLR2, BCL2, IFNA21, MALT1 | More | | Benazepril | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Benazepril | hsa05163 | Human cytomegalovirus infection | 4.73E-02 | 6 | P62873, Q14643, P0DP23, P17252, Q13546, P01568 | GNB1, ITPR1, CALM1, PRKCA, RIPK1, IFNA21 | More | | Benazepril | hsa05170 | Human immunodeficiency virus 1 infection | 1.16E-03 | 10 | P62873, P0DP23, P17252, Q13546, Q14643, P01568, O60603, P23528, P10415, Q9Y6Q5 | GNB1, CALM1, PRKCA, RIPK1, ITPR1, IFNA21, TLR2, CFL1, BCL2, AP1M2 | More | | Benazepril | hsa05200 | Pathways in cancer | 2.03E-03 | 19 | Q13751, P17301, P42338, P08238, P19174, P43246, P84022, Q13485, P20585, Q13547, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P14784 | LAMB3, ITGA2, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, MSH3, HDAC1, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, IL2RB | More | | Benazepril | hsa05205 | Proteoglycans in cancer | 4.46E-02 | 4 | Q12955, Q14247, P17252, P08962 | ANK3, CTTN, PRKCA, CD63 | More | | Benazepril | hsa05212 | Pancreatic cancer | 9.39E-03 | 5 | P42338, P37173, P84022, Q13485, O75293 | PIK3CB, TGFBR2, SMAD3, SMAD4, GADD45B | More | | Benazepril | hsa05214 | Glioma | 2.66E-02 | 3 | Q16566, P04637, P24522 | CAMK4, TP53, GADD45A | More | | Benazepril | hsa05216 | Thyroid cancer | 2.72E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Benazepril | hsa05217 | Basal cell carcinoma | 4.79E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Benazepril | hsa05218 | Melanoma | 2.72E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Benazepril | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Benazepril | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.27E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | | Benazepril | hsa05310 | Asthma | 1.35E-02 | 2 | P13765, P29965 | HLA-DOB, CD40LG | More | | Benazepril | hsa05320 | Autoimmune thyroid disease | 3.16E-02 | 2 | P13765, P29965 | HLA-DOB, CD40LG | More | | Benazepril | hsa05330 | Allograft rejection | 1.76E-03 | 4 | P13765, P29965, P48023, P01375 | HLA-DOB, CD40LG, FASLG, TNF | More | | Benazepril | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Benazepril | hsa05410 | Hypertrophic cardiomyopathy | 2.63E-02 | 1 | P17301 | ITGA2 | More | | Benazepril | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 8.47E-04 | 4 | P14923, P17301, P08514, Q9UJU2 | JUP, ITGA2, ITGA2B, LEF1 | More | | Benazepril | hsa05415 | Diabetic cardiomyopathy | 1.28E-02 | 4 | Q16718, O14521, Q16539, P49841 | NDUFA5, SDHD, MAPK14, GSK3B | More | | Benazepril | hsa05416 | Viral myocarditis | 4.29E-02 | 2 | P13765, P29965 | HLA-DOB, CD40LG | More | | |